Literature DB >> 23561454

The IAEA technical cooperation programme and nuclear medicine in the developing world: objectives, trends, and contributions.

Juan Antonio Casas-Zamora1, Ridhi Kashyap.   

Abstract

The International Atomic Energy Agency's technical cooperation (TC) programme helps Member States in the developing world with limited infrastructure and human resource capacity to harness the potential of nuclear technologies in meeting socioeconomic development challenges. As a part of its human health TC initiatives, the Agency, through the TC mechanism, has the unique role of promoting nuclear medicine applications of fellowships, scientific visits, and training courses, via technology procurement, and in the past decade has contributed nearly $54 million through 180 projects in supporting technology procurement and human resource capacity development among Member States from the developing world (low- and middle-income countries). There has been a growing demand in nuclear medicine TC, particularly in Africa and ex-Soviet Union States where limited infrastructure presently exists, based on cancer and cardiovascular disease management projects. African Member States received the greatest allocation of TC funds in the past 10 years dedicated to building new or rehabilitating obsolete nuclear medicine infrastructure through procurement support of single-photon emission computed tomography machines. Agency support in Asia and Latin America has emphasized human resource capacity building, as Member States in these regions have already acquired positron emission tomography and hybrid modalities (positron emission tomography/computed tomography and single-photon emission computed tomography/computed tomography) in their health systems. The strengthening of national nuclear medicine capacities among Member States across different regions has enabled stronger regional cooperation among developing countries who through the Agency's support and within the framework of regional cooperative agreements are sharing expertise and fostering the sustainability and productive integration of nuclear medicine within their health systems.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23561454     DOI: 10.1053/j.semnuclmed.2012.11.007

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  3 in total

1.  Current status of nuclear cardiology practice in Latin America and the Caribbean.

Authors:  Diana Paez; Amalia Peix; Pilar Orellana; Joao Vitola; Fernando Mut; Claudia Gutiérrez; Crosby Plaza; Tarik Becic; Maurizio Dondi; Enrique Estrada
Journal:  J Nucl Cardiol       Date:  2016-08-29       Impact factor: 5.952

2.  Trends in the utilization of nuclear medicine technology in Jamaica: Audit of a private facility.

Authors:  Tracia-Gay Kennedy-Dixon; Karlene McDonnough; Marvin Reid; Maxine Gossell-Williams
Journal:  World J Nucl Med       Date:  2020-09-14

3.  Inter-reader variability of SPECT MPI readings in low- and middle-income countries: Results from the IAEA-MPI Audit Project (I-MAP).

Authors:  Maurizio Dondi; Carlo Rodella; Raffaele Giubbini; Luca Camoni; Ganesan Karthikeyan; Joao V Vitola; Andrew J Einstein; Bertjan J Arends; Olga Morozova; Thomas N Pascual; Diana Paez
Journal:  J Nucl Cardiol       Date:  2018-08-30       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.